[Thrombocytic diseases in generalized myasthenia gravis and their correction by using plasmapheresis and administration of anti- immunoglobulin antisera].
Platelet adhesion and aggregation studies were performed in different test systems in 25 patients with plasmapheresis-treated myasthenia patients. In vivo studies with plasmapheresis and in vitro investigation with anti-immunoglobulin antisera revealed the normalization of the impaired platelet functions.
Shimkevich
L L
LL
Rudneva
V G
VG
Sapin
S M
SM
Marchuk
A I
AI
Golovteev
V V
VV
D001791:Blood Platelet Disorders / Q000209:etiology*; D001792:Blood Platelets / Q000502:physiology*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007106:Immune Sera / Q000276:immunology; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000276:immunology; D066298:In Vitro Techniques; D008297:Male; D009157:Myasthenia Gravis / Q000097:blood* / Q000150:complications; D010956:Plasmapheresis; D010973:Platelet Adhesiveness / Q000502:physiology; D010974:Platelet Aggregation / Q000502:physiology; D013915:Thrombasthenia / Q000209:etiology* / Q000628:therapy
D007106:Immune Sera; D007136:Immunoglobulins
Trombotsitarnye narusheniia pri generalizovannoĭ miastenii i ikh korrektsiia s pomo'shchiu plazmafereza i vvedeniia anti- syvorotok k immunoglobulinam.